LSE:AZN (AstraZeneca PLC)
About AZN
AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
AstraZeneca PLC (LSE: AZN) Latest News
Investing Articles
This is how many FTSE 100 shares I’d likely need for £1,000 a month in passive income
Investing Articles
What does the UK recession mean for FTSE 100 stocks?
Investing Articles
FTSE 100 earnings: why did the AstraZeneca share price fall 7%?
Investing Articles
As the AstraZeneca share price dips on results day, I ask if the stock is too high
Investing Articles
3 top FTSE 100 stocks that easily pass the ‘snap test’
Investing Articles
£7,000 to invest? I’d consider these stocks in the FTSE 100 right now
Investing Articles
They outperformed the S&P 500 over 5 years! Are these the best UK shares to buy now?
Investing Articles
How I’d invest £20,000 in a Stocks and Shares ISA to target lifelong passive income
Investing Articles
Down more than 10% in 2023, Fools are backing these 5 UK stocks to reverse that – and then some! – in 2024
Investing Articles
If I had to buy just one FTSE 100 stock in 2024, it would be this
Investing Articles
Are these 2 FTSE 100 companies recession-resistant?